ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, invites investors to view a new video providing an overview of the Company’s unique technologies as well as its overall strategies to develop breakthrough medical therapies for a variety of serious diseases and degenerative conditions.
